{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:09:26Z","timestamp":1788880166242,"version":"build-2803163510"},"reference-count":37,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR169162"],"award-info":[{"award-number":["NIHR169162"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoporosis is a systemic skeletal disorder characterised by bone tissue deterioration, leading to reduced bone density and increased susceptibility to fractures. Osteoporosis screening is the process of identifying people with an increased risk of osteoporosis by using risk assessment tools or medical imaging. The National Institute for Health and Care Excellence recommends opportunistic risk assessment in women over 65 years or under 65 years with risk factors, though this guideline was last updated in 2017. Regular surveillance of the available evidence is warranted to gauge the volume and type of evidence published on key issues relating to population-based and targeted screening for osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-2\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify and review the volume and type of evidence on effectiveness and cost-effectiveness of population-based and targeted osteoporosis screening in women and to explore the consideration of health equity in the evidence base.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-3\">\n                    <jats:title>Design and methods<\/jats:title>\n                    <jats:p>Two information specialists developed the search strategy in MEDLINE (via Ovid) and translated it to 10 other databases.<\/jats:p>\n                    <jats:p>The title and abstract then full text of each record were screened by two independent reviewers. Disagreements were resolved through discussion. Records found through supplementary searches were single-screened as were reference lists of relevant guidelines identified.<\/jats:p>\n                    <jats:p>One reviewer completed data extraction of included studies, with a second reviewer checking the accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-4\">\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>Included studies were required to be experimental designs, systematic reviews or cost-effectiveness studies with a standard care comparator. Populations of interest were women over 65 years and women below 65 years with osteoporosis risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-5\">\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Any population or targeted screening intervention involving any combination of risk assessment and dual energy X-ray absorptiometry scan designed to identify women with, or at risk for, osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-6\">\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Outcomes related to osteoporosis prevention (osteoporotic fractures, all-cause fractures and mortality), possible screening harms and cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-7\">\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Searches were conducted in 11 databases and were supplemented by forward and backward citation searching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-8\">\n                    <jats:title>Review methods<\/jats:title>\n                    <jats:p>Study characteristics and equity considerations were tabulated and narratively described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 19 included studies consisted of 3 randomised controlled trials with 9 sibling papers, 1 non-concurrent cohort study and 6 reviews. The primary studies generally included women 65 years old and older, with interventions involving several risk assessment and screening methods. Most reviews investigated the general population and included either bone mineral density measurement or clinical risk assessment for screening. Studies mainly reported fracture outcomes, with some quality-of-life and cost-effectiveness measures. Equity-relevant features analysed by studies included education, relationships, income and age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-10\">\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>Our inclusion criteria may have excluded some evidence discussed by other related reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-11\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence on the effectiveness and cost-effectiveness of osteoporosis screening is limited, with reviews mainly drawing conclusions from the same few primary studies currently available. The evidence base lacks consideration of equity-related characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-12\">\n                    <jats:title>Future work<\/jats:title>\n                    <jats:p>High-quality trial evidence is required, particularly for targeted screening. Equity characteristics should be addressed in future work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-13\">\n                    <jats:title>Anticipated impact and dissemination<\/jats:title>\n                    <jats:p>The review aims to identify gaps in the current evidence base for targeted and population osteoporosis screening to inform future research and healthcare policy-makers\u2019 decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-14\">\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme as award number NIHR169162.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3310\/gjjt0804","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T10:14:56Z","timestamp":1754302496000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and cost-effectiveness of targeted and population screening for osteoporosis in women: scoping review"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8813-0258","authenticated-orcid":true,"given":"Kieran","family":"Becker","sequence":"first","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-7162","authenticated-orcid":true,"given":"Morgan","family":"Weiland","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-664X","authenticated-orcid":true,"given":"Samantha","family":"Febrey","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-0911","authenticated-orcid":true,"given":"Michael","family":"Nunns","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1533-6862","authenticated-orcid":true,"given":"Jill","family":"Buckland","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-4484","authenticated-orcid":true,"given":"Rebecca","family":"Abbott","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8379-8198","authenticated-orcid":true,"given":"Rebecca","family":"Whear","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-9201","authenticated-orcid":true,"given":"Alison","family":"Bethel","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-5019","authenticated-orcid":true,"given":"Elizabeth","family":"Shaw","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-5488","authenticated-orcid":true,"given":"Kate","family":"Boddy","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-4790","authenticated-orcid":true,"given":"GJ","family":"Melendez-Torres","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-0234","authenticated-orcid":true,"given":"Joanna","family":"Thompson Coon","sequence":"additional","affiliation":[{"name":"Isca Evidence, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"key2026090817584600_ref1-bib1","volume-title":"Osteoporosis","author":"NHS Inform","year":"2025"},{"key":"key2026090817584600_ref2-bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporosis"},{"key":"key2026090817584600_ref3-bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","article-title":"The components of excess mortality after hip fracture","volume":"32","author":"Kanis","year":"2003","journal-title":"Bone"},{"key":"key2026090817584600_ref4-bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2014.02.016","article-title":"Mortality following the first hip fracture in Norwegian women and men (1999\u20132008). A NOREPOS study","volume":"63","author":"Omsland","year":"2014","journal-title":"Bone"},{"key":"key2026090817584600_ref5-bib5","doi-asserted-by":"crossref","first-page":"ziae002","DOI":"10.1093\/jbmrpl\/ziae002","article-title":"Postfracture survival in a population-based study of adults aged >=66 yr: a call to action at hospital discharge","volume":"8","author":"Vincent","year":"2024","journal-title":"JBMR Plus"},{"key":"key2026090817584600_ref6-bib6","volume-title":"Osteoporosis: Assessing the Risk of Fragility Fracture Clinical Guideline [CG146]","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"key2026090817584600_ref7-bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2024.27154","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"333","author":"Nicholson","year":"2025","journal-title":"JAMA"},{"key":"key2026090817584600_ref8-bib8","volume-title":"Screening for Osteoporosis in Postmenopausal Women","author":"Solutions for Public Health","year":"2019"},{"key":"key2026090817584600_ref9-bib9","volume-title":"PROGRESS-Plus","author":"Cochrane","year":"2024"},{"key":"key2026090817584600_ref10-bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref11-bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jbmr.3815","article-title":"The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial","volume":"34","author":"Merlijn","year":"2019","journal-title":"J Bone Miner Res"},{"key":"key2026090817584600_ref12-bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-142-3-200502010-00007","article-title":"Association between screening for osteoporosis and the incidence of hip fracture","volume":"142","author":"Kern","year":"2005","journal-title":"Ann Intern Med"},{"key":"key2026090817584600_ref13-bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-019-05226-w","article-title":"Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis","volume":"31","author":"Merlijn","year":"2020","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref14-bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13643-023-02181-w","article-title":"Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools","volume":"12","author":"Gates","year":"2023","journal-title":"Syst Rev"},{"key":"key2026090817584600_ref15-bib15","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2018.6537","article-title":"Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Viswanathan","year":"2018","journal-title":"JAMA"},{"key":"key2026090817584600_ref16-bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00198-022-06659-6","article-title":"The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review","volume":"34","author":"Auais","year":"2023","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref18-bib18","volume-title":"What Evidence Is There for the Prevention and Screening of Osteoporosis?","author":"Johnell","year":"2006"},{"key":"key2026090817584600_ref19-bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jbmr.3381","article-title":"The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP Study","volume":"33","author":"Turner","year":"2018","journal-title":"J Bone Miner Res"},{"key":"key2026090817584600_ref20-bib20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jbmr.3411","article-title":"Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures-a post hoc analysis of the SCOOP Study","volume":"33","author":"McCloskey","year":"2018","journal-title":"J Bone Miner Res"},{"key":"key2026090817584600_ref21-bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00198-019-05270-6","article-title":"Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study","volume":"31","author":"Condurache","year":"2020","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref22-bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00198-019-05142-z","article-title":"Systematic screening using FRAX R leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial","volume":"31","author":"Parsons","year":"2020","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref23-bib23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00198-020-05372-6","article-title":"Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study","volume":"31","author":"Soreskog","year":"2020","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref24-bib24","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1007\/s00198-017-4205-y","article-title":"Non-participation in systematic screening for osteoporosis \u2013 the ROSE trial","volume":"28","author":"Rothmann","year":"2017","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref25-bib25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00198-019-04934-7","article-title":"Use of antiosteoporotic medication in the Danish ROSE population-based screening study","volume":"30","author":"Hoiberg","year":"2019","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref26-bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00198-018-4768-2","article-title":"Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study","volume":"30","author":"Holmberg","year":"2019","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref27-bib27","doi-asserted-by":"crossref","first-page":"102584","DOI":"10.1016\/j.eclinm.2024.102584","article-title":"Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial","volume":"71","author":"Petersen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"key2026090817584600_ref28-bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet"},{"key":"key2026090817584600_ref29-bib29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","article-title":"The international costs and utilities related to osteoporotic fractures study (ICUROS) \u2013 quality of life during the first 4 months after fracture","volume":"24","author":"Borgstr\u00f6m","year":"2013","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref30-bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40620-017-0375-0","article-title":"Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review","volume":"31","author":"Gheewala","year":"2018","journal-title":"J Nephrol"},{"key":"key2026090817584600_ref31-bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13063-017-2099-9","article-title":"Barriers to the conduct of randomised clinical trials within all disease areas","volume":"18","author":"Djurisic","year":"2017","journal-title":"Trials"},{"key":"key2026090817584600_ref32-bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00198-009-1007-x","article-title":"Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk","volume":"21","author":"Barr","year":"2010","journal-title":"Osteoporos Int"},{"key":"key2026090817584600_ref33-bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005650-200503000-00012","article-title":"Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial","volume":"43","author":"Lacroix","year":"2005","journal-title":"Med Care"},{"key":"key2026090817584600_ref34-bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jbmr.1478","article-title":"Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for Skeletal Health in Bristol and Avon (COSHIBA)","volume":"27","author":"Clark","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key2026090817584600_ref35-bib35","volume-title":"National Healthcare Inequalities Improvement Programme","author":"NHS England","year":"2021"},{"key":"key2026090817584600_ref36-bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Info Libr J"},{"key":"key2026090817584600_ref37-bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"key2026090817584600_ref38-bib38","volume-title":"Osteoporosis \u2013 Prevention of Fragility Fractures (Clinical Knowledge Summaries)","author":"National Institute for Health and Care Excellence (NICE)","year":"2025"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2050624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/GJJT0804\/GJJT0804.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2050624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:38:37Z","timestamp":1788878317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/published-articles\/GJJT0804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"alternative-id":["10.3310\/GJJT0804"],"URL":"https:\/\/doi.org\/10.3310\/gjjt0804","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"11-2024","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"05-2025","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"09-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}